Although
selenocysteine selenenic acids (Sec–SeOHs) have
been recognized as key intermediates in the catalytic cycle of glutathione
peroxidase (GPx), examples of the direct observation of Sec–SeOH
in either protein or small-molecule systems have remained elusive
so far, mostly due to their instability. Here, we report the first
direct spectroscopic (1H and 77Se NMR) evidence
for the formation of Sec–SeOH in small-molecule selenocysteine
and selenopeptide model systems with a cradle-type protective group.
The catalytic cycle of GPx was investigated using NMR-observable Sec–SeOH
models. All the hitherto proposed chemical processes, i.e., not only
those of the canonical catalytic cycle but also those involved in
the bypass mechanism, including the intramolecular cyclization of
Sec–SeOH to the corresponding five-membered ring selenenyl
amide, were examined in a stepwise manner.
Abstract:A primary-alkyl-substituted selenenyl iodide was successfully synthesized through oxidative iodination of a selenol with N-iodosuccinimide by taking advantage of a cavity-shaped steric protection group. The selenenyl iodide exhibited high thermal stability and remained unchanged upon heating at 100˝C for 3 h in [D 8 ]toluene. The selenenyl iodide was reduced to the corresponding selenol by treatment with dithiothreitol. Hydrolysis of the selenenyl iodide under alkaline conditions afforded the corresponding selenenic acid almost quantitatively, corroborating the chemical validity of the recent proposal that hydrolysis of a selenenyl iodide to a selenenic acid is potentially involved in the catalytic mechanism of an iodothyronine deiodinase.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.